People: Salix Pharmaceuticals Ltd (SLXP.OQ)

SLXP.OQ on NASDAQ Stock Exchange Global Select Market

131.26USD
22 Jul 2014
Price Change (% chg)

$1.12 (+0.86%)
Prev Close
$130.14
Open
$130.77
Day's High
$134.04
Day's Low
$130.26
Volume
193,500
Avg. Vol
350,896
52-wk High
$141.28
52-wk Low
$65.00

Search Stocks

Logan, Carolyn 

Brief Biography

Ms. Carolyn J. Logan is President, Chief Executive Officer, Director of Salix Pharmaceuticals Ltd. She previously served as Senior Vice President, Sales and Marketing from June 2000 to July 2002. Prior to joining Salix, Ms. Logan served as Vice President, Sales and Marketing of the Oclassen Dermatologics Division of Watson Pharmaceuticals, Inc., a specialty pharmaceutical company, from May 1997 to June 2000, and as its Vice President, Sales from February 1997 to May 1997. Prior to that date, she served as Director, Sales of Oclassen Pharmaceuticals, Inc. from January 1993 to February 1997. Prior to joining Oclassen, Ms. Logan held various sales and marketing positions with Galderma Laboratories, focused on developing dermatology treatments, Ulmer Pharmacal and Westwood Pharmaceuticals, now known as Westwood-Squibb Pharmaceuticals, Inc., a subsidiary of Bristol-Myers Squibb, a global biopharmaceutical company. Ms. Logan received a B.S. degree in Biology and Dental Hygiene from the University of North Carolina at Chapel Hill.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
867,450 -- 1,146,020 6,600,960

Options Compensation

  Quantity Market Value
Exercisable 612,126 6,654,690.00
Unexercisable 215,202 1,743,050.00
Exercised 318,751 14,892,400.00
Name Fiscal Year Total

Thomas D'Alonzo

--

Carolyn Logan

6,600,960

Adam Derbyshire

2,039,990

William Forbes

1,968,770

Rick Scruggs

1,802,050

John Chappell

--
As Of 30 Dec 2013
Search Stocks